NKGen Biotech Korea Co., Ltd. (KOSDAQ: A182400)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
NKGen Biotech Korea Co., Ltd. (KOSDAQ: A182400) operates in the Biotechnology industry within the Health Care sector. The company is valued at $128.86M.
trading between 7.36K and 38.97K.
Tweenvest scores NKGen Biotech Korea Co., Ltd. across four factors: quality 42/100, value 47/100. Its strongest factor is value.
A182400 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $128.86M
- Revenue (TTM)
- $5.25M
- P/E
- —
- EPS
- -18.42
- Dividend yield
- —
- Beta (5Y)
- 0.66
- 52-week high
- ₩38,973.75
- 52-week low
- ₩7,362.50
- Avg volume (3M)
- —
- Shares outstanding
- 18.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| StemCyte International, Ltd.TWSE: 4178 | $132.32M | NT$19.60 | +8.89% |
| Saniona AB (publ)OM: SANION | $132.11M | Skr9.57 | -0.26% |
| Orthocell LimitedASX: OCC | $131.16M | AU$0.69 | -9.21% |
| Tenaya Therapeutics, Inc.NasdaqCM: TNYA | $130.12M | $0.57 | -2.55% |
| Spruce Biosciences, Inc.NasdaqCM: SPRB | $126.60M | $42.87 | -2.68% |
| Bio Solution Co.,Ltd.KOSDAQ: A086820 | $126.49M | ₩6,590.00 | -1.64% |
| Pharma Foods International Co., Ltd.TSE: 2929 | $126.01M | ¥687.00 | +1.33% |
| Aroa Biosurgery LimitedASX: ARX | $125.52M | AU$0.52 | +6.12% |
Figures last refreshed Oct 11, 2026.